CN Patent

CN108697811A — 抑制共济失调毛细血管扩张和Rad3相关蛋白(ATR)

Assigned to Jazz Pharmaceuticals Inc · Expires 2018-10-23 · 8y expired

What this patent protects

抑制ATR蛋白激酶的新颖化合物包括本文公开的式(I)化合物，以及包含ATR蛋白激酶抑制剂化合物的脂质体制剂。所述组合物可用于治疗癌症。

USPTO Abstract

抑制ATR蛋白激酶的新颖化合物包括本文公开的式(I)化合物，以及包含ATR蛋白激酶抑制剂化合物的脂质体制剂。所述组合物可用于治疗癌症。

Drugs covered by this patent

Patent Metadata

Patent number
CN108697811A
Jurisdiction
CN
Classification
—
Expires
2018-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.